Sollievo Pharmaceuticals

Sollievo Pharmaceuticals is seeking to improve safety for healthcare staff with our first product, Proviza. Proviza is a fast-acting sedative developed to address the rising incidence of injuries and abuse to healthcare staff when treating agitated and aggressive patients. Sollievo Pharmaceuticals is pre-revenue and in the development and scale-up stages.

StartEngine OWNERS Exclusive Click here to learn more

$200+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Super Early Bird Bonus
Invest within the first four weeks and receive 20% bonus shares.




27
days

14
hours

14
mins

19
secs

$500+ Investment
Company Bonus
Invest $500+ and receive 5% bonus shares.

$1,000+ Investment
Silver Bonus
Invest $1,000+ and receive 10% bonus shares.

$5,000+ Investment
Gold Bonus
Invest $5,000+ and receive 15% bonus shares.

$10,000+ Investment
Platinum Bonus
Invest $10,000+ and receive 20% bonus shares

7 out of 10 emergency physicians say emergency department violence is increasing and half have been physically assaulted at work. Proviza was developed to address this public health crisis.*

We believe Sollievo has the potential of disrupting the estimated $1.2B global intramuscular agitation and aggression treatment market by introducing one of the fastest acting intramuscular solutions compared to competitors on the market today.**

Sollievo's leadership and consulting team represents more than 100 years of combined experience in the pharmaceutical and medical industries.

Peter Schineller



Commercial Strategic Advisor


During his 35-year career, Mr. Schineller has held executive positions, CMO, SVP, and CCO at major pharmaceutical companies, including Novartis, Abbott, and Pfizer. He co-founded Veras Pharmaceuticals where he was the CCO. Novartis acquired the Veras product line. Mr. Schineller's success in commercializing drug products makes him an ideal advisor to guide the company's marketing and commercial launch strategies to ensure the successful uptake of its lead product Proviza. 
With Sollievo, Peter works on average 1 hour per week and on an as-needed basis. 















Anthony Coniglio, PharmD



Strategic Clinical/Commercial Advisor


Dr. Coniglio has focused his 30-year career in medical, commercial strategy, and business development at BMS, Pharmacia, and Medpointe. He founded his consulting practice to provide business development, medical, and marketing for major brands. At Sollievo, Dr. Coniglio will advise the company on the interface between clinical, marketing, and approval of Proviza. He will be instrumental in developing the strategy that ensures broad acceptance of Proviza, clearing the way for rapid hospital formulary approval. 
With Sollievo, Anthony works on average 1 hour per week and on an as-needed basis.